Superior Planning, LLC’s GSK GSK Stock Holding History

Superior Planning, LLC’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$46.5K	Buy	+965	New	+$49.3K	0.02%	399

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

JTC Employer Solutions Trustee St Helier, Jersey $1.16B AUM 24.39% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Mondrian Investment Partners London, United Kingdom $5.39B AUM 14.53% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Equity Investment Corp Atlanta, Georgia $5.3B AUM 8.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return

Superior Planning, LLC's GSK Position: Q3 2026 in Review

Superior Planning, LLC opened a new position in GSK (GSK) in Q3 2026: 965 shares worth $46.5K. The stake represents 0.02% of the portfolio and ranks #399 among its holdings.

732 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

Superior Planning, LLC held 965 shares of GSK worth $46.5K as of Q3 2026.
GSK was a new Superior Planning, LLC position in Q3 2026.
GSK made up 0.02% of Superior Planning, LLC's portfolio in Q3 2026, its #399 holding.
732 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Superior Planning, LLC's 13F filing for Q3 2026, filed 12 Nov 2026.